Recent advancements in the field of diabetes treatment have introduced a promising class of medications known as GLP-1 receptor agonists. These drugs work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://emilylton969307.blogrenanda.com/47192594/novel-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide